#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5123995	F	Antileishmanial activity against intracellular Leishmania infantum MHOM/MA(BE)/67 ITMAP263 amastigotes infected in Swiss mouse peritoneal macrophage assessed as inhibition of parasite growth measured after 5 days by geimsa staining based microscopic analysis	Leishmania infantum	46		organism-based format	Scientific Literature
2.	ALA5123996	T	Cytotoxicity against Swiss mouse peritoneal macrophages assessed as reduction in cell viability measured after 5 days by microscopic analysis	Mus musculus	46		cell-based format	Scientific Literature
3.	ALA5123997	T	Selectivity index, ratio of CC50 for Cytotoxicity against Swiss mouse peritoneal macrophages to EC50 for intracellular Leishmania infantum MHOM/MA(BE)/67 ITMAP263 amastigotes infected in Swiss mouse peritoneal macrophages		45		cell-based format	Scientific Literature
4.	ALA5123998	T	Cytotoxicity against human MRC5 cells assessed as reduction in cell viability incubated for 3 days by resazurin dye based fluorescence analysis	Homo sapiens	39		cell-based format	Scientific Literature
5.	ALA5123999	F	Antileishmanial activity against sodium stibogluconate and potassium antimonyl tartrate resistant intracellular Leishmania infantum MHOM/FR/96/LEM3323-CI4 promastigotes infected in Swiss mouse peritoneal macrophages assessed as inhibition of parasite growth measured after 96 hrs by microscopic analysis	Leishmania infantum	2		organism-based format	Scientific Literature
6.	ALA5124000	F	Antileishmanial activity against sodium stibogluconate, potassium antimonyl tartrate and MIL resistant intracellular Leishmania infantum MHOM/FR/96/LEM3323-CI4 MIL5C13 promastigotes infected in Swiss mouse peritoneal macrophages assessed as inhibition of parasite growth measured after 96 hrs by microscopic analysis	Leishmania infantum	2		organism-based format	Scientific Literature
7.	ALA5124001	F	Antileishmanial activity against sodium stibogluconate, potassium antimonyl tartrate and PMM resistant intracellular Leishmania infantum MHOM/FR/96/LEM3323-CI4 PMM promastigotes infected in Swiss mouse peritoneal macrophages assessed as inhibition of parasite growth measured after 96 hrs by microscopic analysis	Leishmania infantum	2		organism-based format	Scientific Literature
8.	ALA5124002	F	Antitrypanosomal activity against nifurtimox-sensitive Tulahuen CL2 amastigotes expressing beta galactosidase infected in human MRC5 cells assessed as inhibition of parasite growth using chlorophenol red beta-D-galactopyranoside as substrate and measured after 7 days by spectrophotometric analysis	Trypanosoma cruzi	12		organism-based format	Scientific Literature
9.	ALA5124003	A	Metabolic stability in golden hamster liver microsomes S9 fraction assessed as CYP450-mediated metabolism by measuring parent compound remaining measured after 60 mins in presence of NADPH	Mesocricetus auratus	2		subcellular format	Scientific Literature
10.	ALA5124004	A	Metabolic stability in golden hamster liver microsomes S9 fraction assessed as CYP450-mediated metabolism by measuring parent compound remaining measured after 30 mins in presence of NADPH	Mesocricetus auratus	2		subcellular format	Scientific Literature
11.	ALA5124005	A	Metabolic stability in golden hamster liver microsomes S9 fraction assessed as CYP450-mediated metabolism by measuring parent compound remaining measured after 15 mins in presence of NADPH	Mesocricetus auratus	2		subcellular format	Scientific Literature
12.	ALA5124006	A	Metabolic stability in mouse liver microsomes S9 fraction assessed as UGT-mediated metabolism by measuring parent compound remaining measured after 60 mins in presence of NADPH	Mus musculus	2		subcellular format	Scientific Literature
13.	ALA5124007	A	Metabolic stability in mouse liver microsomes S9 fraction assessed as UGT-mediated metabolism by measuring parent compound remaining measured after 30 mins in presence of NADPH	Mus musculus	2		subcellular format	Scientific Literature
14.	ALA5124008	A	Metabolic stability in mouse liver microsomes S9 fraction assessed as CYP450-mediated metabolism by measuring parent compound remaining measured after 60 mins in presence of NADPH	Mus musculus	2		subcellular format	Scientific Literature
15.	ALA5124009	A	Metabolic stability in mouse liver microsomes S9 fraction assessed as CYP450-mediated metabolism by measuring parent compound remaining measured after 30 mins in presence of NADPH	Mus musculus	2		subcellular format	Scientific Literature
16.	ALA5124010	A	Metabolic stability in mouse liver microsomes S9 fraction assessed as CYP450-mediated metabolism by measuring parent compound remaining measured after 15 mins in presence of NADPH	Mus musculus	2		subcellular format	Scientific Literature
17.	ALA5124011	T	Selectivity index, ratio of CC50 for cytotoxicity against human MRC5 cells to EC50 for Trypanosoma cruzi Tulahuen CL2 amastigotes expressing beta galactosidase infected in human MRC5 cells		12		cell-based format	Scientific Literature
18.	ALA5124012	A	Metabolic stability in mouse liver microsomes S9 fraction assessed as UGT-mediated metabolism by measuring parent compound remaining measured after 15 mins in presence of NADPH	Mus musculus	2		subcellular format	Scientific Literature
19.	ALA5124014	A	Metabolic stability in golden hamster liver microsomes S9 fraction assessed as UGT-mediated metabolism by measuring parent compound remaining measured after 15 mins in presence of NADPH	Mesocricetus auratus	2		subcellular format	Scientific Literature
20.	ALA5124015	A	Metabolic stability in golden hamster liver microsomes S9 fraction assessed as UGT-mediated metabolism by measuring parent compound remaining measured after 30 mins in presence of NADPH	Mesocricetus auratus	2		subcellular format	Scientific Literature